Table 2.
Frequency of autoantibody to CIP2A in sera from patients with lung cancer
Type of diseases | No. tested | Frequency (Patients with anti-CIP2A/total patients with disease)a |
---|---|---|
Lung Cancer | 105 | 25.7 %(27/105)**b |
Normal human sera (NHS) | 82 | 4.9 % (4/82)**b |
a Cutoff value: Mean + 3 SD of NHS
bP value relative to NHS: * p < 0.05; ** p < 0.01